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Beetroot (甜菜 tian cai) juice consumption is of current interest for improving aerobic performance by
acting as a vasodilator and possibly through alterations in skeletal muscle metabolism and physiology.
This work explored the effects of a commercially available beetroot supplement on metabolism, gene
expression, and mitochondrial content in cultured myocytes. C2C12 myocytes were treated with various
concentrations of the beetroot supplement for various durations. Glycolytic metabolism and oxidative
metabolism were quantiﬁed via measurement of extracellular acidiﬁcation and oxygen consumption,
respectively. Metabolic gene expression was measured using quantitative reverse transcriptionepoly-
merase chain reaction, and mitochondrial content was assessed with ﬂow cytometry and confocal mi-
croscopy. Cells treated with beetroot exhibited signiﬁcantly increased oxidative metabolism,
concurrently with elevated metabolic gene expression including peroxisome proliferator-activated re-
ceptor gamma coactivator-1 alpha, nuclear respiratory factor 1, mitochondrial transcription factor A, and
glucose transporter 4, leading to increased mitochondrial biogenesis. Our data show that treatment with
a beetroot supplement increases basal oxidative metabolism. Our observations are also among the ﬁrst to
demonstrate that beetroot extract is an inducer of metabolic gene expression and mitochondrial
biogenesis. These observations support the need for further investigation into the therapeutic and
pharmacological effects of nitrate-containing supplements for health and athletic beneﬁts.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Dietary sources of nitrate are found in a variety of foods
including roots and green leafy vegetables, and more recently,
some cured/processed meats. Dietary sources of nitrate have
become of interest for ergogenic andmetabolic purposes because of
the ability of dietary nitrate to increase nitric oxide (NO) biosyn-
thesis.1 Nitrate consumption results in heighted plasma nitrite,
which has been previously recognized as an in vivo biomarker of NO
production.2,3 Consumption of nitrate-rich foods prior to endur-
ance events including cycling, rowing, and running results inSciences, Texas Tech Univer-
han).
for Food and Biomolecules,
molecules, National Taiwan Univeimproved performance,4e6 resulting in increasing popularity of
nitrate-containing foods.7e13 As a result, commercially available
dietary products high in nitrate content have emerged as ergogenic
aids purported to increase athletic performance.
NO is a potent cellular stimulus capable of increasing intracel-
lular Ca2þ and cyclic guanosine monophosphate (cGMP) leading to
activation of Ca2þ/calmodulin-dependent protein kinase and 50-
adenosine monophosphate-activated protein kinase (AMPK). Di-
etary NO precursors including arginine and arginine-like metabo-
lites increase NO, stimulating phosphorylation and activation of
AMPK, which later acts to increase the expression and phosphor-
ylation of peroxisome proliferator-activated receptor gamma
coactivator-1 alpha (PGC-1a).14,15 PGC-1a acts as a master meta-
bolic regulator of energy metabolism and mitochondrial biogenesis
by controlling the expression of nuclear respiratory factor (NRF)
and its downstream target, mitochondrial transcription factor A
(TFAM).16e19 In adipocytes, arginine was shown to increasersity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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cold-induced adipocyte browning.20
Despite the heightened interest in nitrate consumption, ﬁndings
about the affects of beetroot (甜菜 tian cai; BR) supplementation
have been inconsistent.10,21e23 The primary aim of this work is to
characterize the effects a commercially available BR supplement
beverage on metabolism and related metabolic gene expression in
skeletal muscle.
2. Materials and methods
2.1. Cell culture
Murine myocytes (C2C12) were purchased from the American
Type Culture Collection (Manassas, VA, USA) and cultured in Dul-
becco's modiﬁed Eagle's medium containing 4500 mg/L glucose
and supplemented with 10% heat-inactivated fetal bovine serum
and 100 U/mL penicillin/streptomycin, in a humidiﬁed 5% CO2 at-
mosphere at 37 C (standard conditions). Following overnight
seeding, cells were treated with various concentrations of the
nitrate-containing commercially available BEET IT Pro-Elite Shot
from James White Drinks Ltd (Ipswich, UK) for 24 hours (in-
gredients are displayed in Table 1).
2.2. Determination of BEET-IT nitrate and nitrite content
BEET IT Pro-Elite's nitrate/nitrite content was quantiﬁed using
the nitrate/nitrite quantiﬁcation assay kit from Cayman Chemical
(Ann Arbor, MI, USA). Nitrate and nitrite were quantiﬁed according
to the manufacturer's protocol. Brieﬂy, nitrate was quantiﬁed by
diluting samples in an assay buffer, followed by 1 hour of incuba-
tion at room temperature with nitrate reductase and vitamin co-
factors. Griess reagents were then added in equivocal volume to
each well and incubated for 10 min at room temperature, and then
sample absorbance was measured at 540 nm. The beverage nitrate
concentrations were 5.312 ± 0.306mM, with undetectable nitrite.
All treatments were standardized to determined nitrate concen-
trations of 20, 10, and 5mM, which correspond with 0.5%, 0.25%, and
0.125% BR, respectively, by volume (determined during preliminary
cell viability and mitochondrial staining studies).
2.3. Metabolic assay
Cells were seeded overnight in 24-well culture plate from Sea-
Horse Bioscience (Billerica, MA, USA) at a density of 5  105 cells/
well, and treated with either control medium or media containing
BR in dilutions corresponding with 0.5%, 0.25%, and 0.125% BR byTable 1
Food fact panel of BEET IT Pro-Elite Shot from James White Drinks Ltd
(Ipswich, UK).
Serving Size 70ml/2.3ﬂ oz
Servings per container 1
Energy/Calories 306kj/72kcal
Protein 2.5 g
Total Carbohydrates 16 g
Sugars 16 g
Total fat <0.1 g
Fiber <0.5 g
Sodium <0.1 g
Dietary Nitrate 0.4 g
Cholesterol 0 g
Vitamin A 0%*
Vitamin C 7.20%*
Calcium 1.20%*
Iron 2.80%*
* % daily values based on a 2000 calorie diet.volume for 24 hours. Following treatment, culture media was
removed and replaced with XF Assay Media from SeaHorse
Bioscience containing 4500 mg/L glucose free of CO2 and brieﬂy
incubated at 37 C. As per the manufacturer's protocol, SeaHorse
injection ports were loaded with oligomycin, an inhibitor of ATP
synthase that induces maximal glycolytic metabolism and reveals
endogenous proton leak (mitochondrial uncoupling) at a ﬁnal
concentration of 1.0 mM. Oligomycin addition was followed by the
addition of carbonyl cyanide p-[triﬂuoromethoxy]-phenyl-hydra-
zone, an uncoupler of electron transport that induces peak oxygen
consumption (an indirect indicator of peak oxidative metabolism)
at ﬁnal concentration of 1.25mM. Rotenone was then added in
1.0mM ﬁnal concentration to reveal nonmitochondrial respiration
and end the metabolic reactions.24,25 Extracellular acidiﬁcation, an
indirect measure of glycolytic capacity, and oxygen consumption, a
measure of oxidative metabolism, was measured using the Sea-
Horse XF24 Extracellular Analyzer from SeaHorse Bioscience. Sea-
Horse XF24 Extracellular Analyzer was run using 8-minute cyclic
protocol commands (mix for 3 minutes, let stand for 2 minutes, and
measure for 3 minutes) in triplicate as previously described.26
2.4. Quantitative real-time polymerase chain reaction
Following a 24-hour treatment with either the control medium
ormedia containing BR in dilutions correspondingwith 0.5%, 0.25%,
and 0.125% BR by volume for various durations up to 24 hours, total
RNAwas extracted using the RNeasy Kit from Qiagen (Valencia, CA,
USA) and cDNA was synthesized using the Retroscript RT kit from
Ambion (Austin, TX, USA) according to manufacturer's instructions.
Polymerase chain reaction (PCR) primers were designed using the
Primer Express software from Invitrogen (Carlsbad, CA, USA) and
synthesized by Integrated DNA Technologies (Coralville, IA, USA).
Ampliﬁcations of PGC-1a, NRF1, TFAM, glucose transporter 4
(GLUT4), and mitochondrial uncoupling protein 3 (UCP3) were
normalized to the housekeeping gene, TATA binding protein (TBP).
Table 2 summarizes the forward and reverse primers of each gene.
Quantitative reverse transcription- polymerase chain reactions
were performed in triplicate using the LightCycler 480 real-time
PCR system from Roche Applied Science (Indianapolis, IN, USA).
SYBRGreen based PCRwas performed in triplicatewith ﬁnal primer
concentrations at 10mM in a total volume of 30 mL. The following
cycling parameters were used: 95C for 10 minutes followed by 45
cycles of 95C for 15 seconds, and 60C for 1 minute. Relative
expression levels were determined using the DDCp method and
compared to the lowest expressing group as previously described.27
2.5. Flow cytometry
Cells were seeded in six-well plates at a density of 1.0  106
cells/well and treated with either control medium or media con-
taining BR in dilutions corresponding with 0.5%, 0.25%, and 0.125%
BR by volume for 24 hours. Following incubation, the medium was
removed and the cells were resuspended in prewarmedmediawith
200nM Mitotracker Green from Life Technologies (Carlsbad, CA,
USA) and incubated for 45 minutes in a humidiﬁed 5% CO2 atmo-
sphere at 37C. The cells were pelleted, the media with Mitotracker
was removed, and the cells were suspended in prewarmed media.
Group mean ﬂuorescence was measured using Facscalibur ﬁltering
488 nm.
2.6. Immunoﬂuorescence and confocal microscopy
To investigate the protein expression of metabolic proteins PGC-
1a, cytochrome C (Cyt C), GLUT4, and UCP3, cells were seeded in
chamber slides obtained from BD Bioscience (Sparks, MD, USA)
Table 2
Summary of qRT-PCR primers from Integrated DNA Technologies (Coralville, IA, USA).
Primer Name Forward Sequence Reverse Sequence
GLUT4 50-GGAGGGAGCCTTTGGTATTT-30 50-CAGGCGAGGACACTCATCTT-30
NRF1 50-ACCCTCAGTCTCACGACTAT-30 50-GAACACTCCTCAGACCCTTAAC-30
PGC-1a 50-GACAATCCCGAAGACACTACAG-30 50-AGAGAGGAGAGAGAGAGAGAGA-30
TBP 50-GGGATTCAGGAAGACCACATA-30 50-CCTCACCAACTGTACCATCAG-30
TFAM 50-GAAGGGAATGGGAAAGGTAGAG-30 50-ACAGGACATGGAAAGCAGATTA-30
GLUT4 ¼ glucose transporter 4; NRF1 ¼ nuclear respiratory factor 1; PGC-1a ¼ peroxisome proliferator-activated receptor g coactivator 1a; qRT-PCR ¼ quantitative reverse
transcription-polymerase chain reaction; TFAM ¼ mitochondrial transcription factor A; TBP ¼ TATA binding protein.
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by volume for 24 hours. Cells were ﬁxed using 3.7% formaldehyde
in media, permeabilized with phosphate-buffered saline (PBS) with
0.1% Triton 100X from Sigma (St. Louis, MO, USA) for 10 minutes,
and blocked for 1 hour with PBS with 0.1% Triton 100X and 3.0%
bovine serum albumin (BSA) purchased from Sigma. Cells were
stained with either an anti-PGC-1a, anti-Cyt C from Santa Cruz
Biotechnologies (Santa Cruz, CA, USA), or an anti-GLUT4 or anti-
UCP3 primary polyclonal-antibody from Abcam (Cambridge, MA,
USA) at 1:200 dilution in PBS with 0.1% BSA overnight. The cells
were rinsed with PBS with 0.1% Triton 100X and 3.0% BSA, and
secondary AlexFluor 488 or AlexFluor 633 from Invitrogen was
applied at 1:200 dilution for 2 hours. Slides were mounted with
Prolong Gold with DAPI from Invitrogen, cured overnight, and
imaged using the Axiovert 25 microscope with AxioCam MRc from
Zeiss (Thornwood, NY, USA).
2.7. Immunoblotting and protein expression
Cellswere treatedwith andwithoutmedia containing 0.5% BR by
volume for 24 hours. Whole-cell lysates were prepared by har-
vesting the cells on ice in high salt lysis buffer (25mM Tris base,
8mM MgCl2, 1mM dithiothreitol, 15% glycerol, 0.1% Triton 100X)
supplemented with protease inhibitor mix (Sigma), followed by
incubation on ice for 60 minutes. The insoluble material was
removed via centrifugation at 17,500  g for 3 minutes, and protein
concentrations were determined using Bradford assay (Protein
Assay Dye Reagent Concentrate; Bio-Rad Laboratories, Hercules, CA,
USA). Total protein (40 mg per sample) was size-separated by 10%
sodium dodecyl sulfate polyacrylamide gel electrophoresis and
electrotransferred to nitrocellulose membranes. After blocking in
TBSTe5% nonfat milk powder for 1 hour, membranes were probed
at 4C for 24 h with an anti-PGC-1a or anti-AMPK primary poly-
clonal antibody from Santa Cruz Biotechnologies, and an anti-b-
actin primary monoclonal antibody from Sigma in TBSTe1% nonfat
milk powder overnight. Bound antibodies were detected by horse-
radish peroxidase-conjugated secondary antibodies from Sigma
and by chemiluminescence using the ECL Plus Western Blotting
Detection kit from GE Healthcare Life Sciences (Little Chalfont,
Buckinghamshire, UK). Signal intensities were obtained by densi-
tometry using the ImageJ software (available from the NIH at http://
rsbweb.nih.gov/ij/) by quantifying lane intensities followed by
normalizing intensity with corresponding b-actin expression.
2.8. Cell viability
Cells were seeded in 96-well plates at a density of 5000 cells/
well and grown overnight. Cells were treated and incubated with
either control medium or media with BR ranging from 0.0025% to
25% by volume for 24 h hours. The medium and treatment were
removed, and media containing 10% WST1 was added to each well
and incubated. Fluorescence was measured 1 hour following WST1
addition using Wallac Victor3V 1420 Multilabel Counter from Per-
kinElmer (Waltham, MA, USA).2.9. Statistical analyses
Metabolic measurements, ﬂow cytometry, and cell viability data
were analyzed using analysis of variance with Dunnett's pairwise
comparisons. Gene expression was quantiﬁed by relative expres-
sion using the DDCp method, and analyzed using analysis of vari-
ance with Dunnett's pairwise comparisons.27 Confocal microscopy
images (performed using 3 randomly selected images), and West-
ern blots were assessed for cellular ﬂuorescence determined by
image J quantiﬁcation and analyzed using Student t tests. All data
are presented as average ± standard deviation normalized to the
control mean (control ¼ 100) with *, **, and *** indicating p < 0.05,
p < 0.01, and p < 0.001 statistical differences compared to control,
respectively.
3. Results
3.1. BR enhances myocyte metabolism
To investigate the effects of BR on myocyte metabolism, we ﬁrst
measured oxygen consumption rate (OCR) following treatment
with and without BR in dilutions corresponding with 0.5%, 0.25%,
and 0.125% BR by volume for 24 hours. Basal OCR was signiﬁcantly
elevated above control levels in cells treated with BR at all tested
volumes, with 0.25% BR yielding the greatest increase in basal
oxidative metabolism (Fig. 1A). Despite the signiﬁcant elevations in
basal oxygen consumption, BR-treated cells exhibited no change in
chemically induced peak oxidative metabolism (Fig. 1B), or mito-
chondrial proton leak (uncoupling) (Fig. 1C). To further investigate
the effects of BR supplementation on myocyte metabolism, we
measured the extracellular acidiﬁcation rate (ECAR), an indirect
measure of glycolytic metabolism. Cells treated with 0.5% or 0.25%
BR exhibited signiﬁcantly reduced basal and peak glycolytic
metabolism compared with control cells (Fig. 1D and E). To deter-
mine the effect of BR treatment on relative metabolic reliance, we
compared the OCR/ECAR ratio of BR-treated cells to control cells.
Cells treated with BR consistently displayed a signiﬁcantly
increased reliance on oxidative metabolism compared with control
cells (Fig. 1F). Taken together, these data suggest that cells treated
with BR and grown in high-glucose media develop a greater pro-
pensity to completely oxidize glucose, leading to increased oxygen
consumption with concurrent reduction in lactate export
(acidiﬁcation).
3.2. BR induces metabolic gene expression
To investigate the effects of BR onmetabolic gene expression, we
treated cells with various percentages of BR for various durations
and assessed the expression of PGC-1a, NRF1, TFAM, GLUT4, and
UCP3, which were normalized to the housekeeping gene, TBP.
Treatment of myocytes with 0.5% BR by volume induced PGC-1a
and GLUT4 expression in a time-dependentmanner comparedwith
the corresponding control. TFAM expression increased 8 hours after
treatment, prior to returning to basal levels at 24 hours after
Fig. 1. Cellular metabolism. (A) Basal oxygen consumption rate (OCR) of cells treated with 0.5%, 0.25%, or 0.125% beetroot (BR) by volume or control medium for 24 hours. (B) Peak
OCR of cells treated as described in the main text. (C) Endogenous proton leak (uncoupling) of cells treated as described in the main text. (D) Basal extracellular acidiﬁcation rate
(ECAR) of cells treated as described in the main text. (E) Peak ECAR of cells treated as described in the main text. (F) Metabolic reliance expressed as the OCR/ECAR ratio of cells
treated as described in the main text. Bar graphs are displayed as complete trial area under the curve (AUC). Note. Data are displayed as group mean ± standard deviation. *p < 0.05,
**p < 0.01, ***p < 0.001 compared with control. yp < 0.05 between 0.5% and 0.125% BR by volume. zp < 0.05 between 0.5% and 0.25% BR by volume.
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all tested time points (Fig. 2A). Additionally, treatment with 0.5%,
0.25%, and 0.125% BR increased PGC-1a and GLUT4 expression
following a 24-hour treatment (Fig. 2B). Furthermore, treatment
with 0.25% and 0.125% BR increased TFAM expression, whereas only
0.25% BR increased NRF1 expression (Fig. 2B). Mitochondrial UCP3
expression was not altered by BR treatment at any of the tested
doses or durations (data not shown). Similar to gene expression,
PGC-1a protein expression was signiﬁcantly elevated following BR
treatment, which led to increased Cyt C content, an indirect indi-
cator of increased mitochondrial content (Fig. 3A). Moreover, while
UCP3 RNA expression was unchanged in BR-treated cells, UCP3
protein expression was signiﬁcantly reduced in cells treated with
BR (Fig. 3A). Also similar to RNA expression, GLUT4 expression was
induced more than 2-fold greater than control cells (Fig. 3A).
Additionally PGC-1a and AMPK protein expression were also
signiﬁcantly elevated in BR-treated cells (Fig. 3B). BR activation of
metabolic gene expression also resulted in a dose-dependentFig. 2. Metabolic gene expression. (A) Expression of peroxisome proliferator-activated rece
chondrial transcription factor A (TFAM), glucose transporter 4 (GLUT4), normalized to the h
with 0.5% beetroot (BR) by volume for 4, 8, or 24 hours. (B) Gene expression of C2C12 myoc
Data are presented as group mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001
between 0.5% and 0.25% BR by volume.increase in myocyte mitochondrial content (Fig. 3C). Following a
24-hour treatment, only treatment with 0.5% BR signiﬁcantly
increased mitochondrial content above control levels. In addition,
cell viability was only signiﬁcantly reduced in C2C12 myocytes
following treatment with 2.5% BR and greater (Fig. 3D).
4. Discussion
Our observations are among the ﬁrst to demonstrate that a BR
supplement beverage can stimulate myocyte metabolism in a
favorable fashion by increasing mitochondrial biogenesis and
oxidative metabolism in a PGC-1a-speciﬁc fashion. Because our
experiments were conducted under high glucose conditions,
increased oxygen consumption with concurrent reductions in
glycolytic acidiﬁcation suggest that BR-treated myocytes undergo a
more complete carbohydrate oxidation. Additionally, our data also
demonstrate that BR can also promote GLUT4 expression, (and
although speculative) nitrate-treatedmyocytesmay have enhancedptor gamma coactivator-1 alpha (PGC-1a), nuclear respiratory factor 1 (NRF-1), mito-
ousekeeping gene, TATA binding protein (TBP) following treatment of C2C12 myocytes
ytes following treatment with 0.5%, 0.25%, or 0.125% BR by volume for 24 hours. Note.
compared with control. yp < 0.05 between 0.5% and 0.125% BR by volume. zp < 0.05
Fig. 3. Protein expression and mitochondrial content. (A) Fluorescent protein expression of C2C12 cells treated with 0.5% BR by volume for 24 hours. (B) Quantiﬁcation of PGC-1a
and AMPK Western blots. (C) Mitochondrial content indicated by group mean log ﬂuorescence measured by ﬂow cytometry of C2C12 cells treated with0.5%, 0.25%, or 0.125% BR by
volume for 24 hours. (D) Cell viability of C2C12 cells treated with BR beverage containing nitrate at various concentrations for 24 hours. AMPK ¼ 50 adenosine monophosphate-
activated protein kinase; BR ¼ beetroot; PGC-1a ¼ proliferator-activated receptor gamma coactivator-1 alpha. Note. Data are presented as group mean ± standard deviation.
*p < 0.05.
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(diabetic) conditions (observations that should be veriﬁed experi-
mentally in vivo). Our observations also demonstrate that BR con-
tainingnitrate increasesmyocytemitochondrial efﬁciency in adose-
dependentmanner,which is ultimately accompanied byan increase
in total mitochondrial content; speciﬁcally increased basal mito-
chondrial metabolism without increased mitochondrial density
following supplementation with 0.25% and 0.125% BR by volume.
Similarly, previous observations by Larsen et al10 showed that
inorganicdietarynitrate consumption inmalehumanvolunteers led
to enhanced mitochondrial efﬁciency with suppressed UCP3 con-
tent inbiopsiedmuscle.Despite reductions inUCP3 content, isolated
mitochondria also displayed unaltered mitochondrial coupling
indicated by oxygen consumption.10 Surprisingly, Larsen also re-
ported no change in isolated mitochondrial oxygen consumption.
Additionally, Larsen et al10 reported no change in PGC-1a or TFAM
RNA content or mitochondrial content. Moreover and contrary to
our ﬁndings, Larsen et al11 previously found that treatment of pri-
mary myotubes with sodium nitrate decreased oxygen consump-
tion. Perhapsmost interesting, sodiumnitrate consumption reduced
resting energy expenditure in healthy individuals.10 This is a
meaningfulﬁndingbecause it suggests thatdespite somepotentially
favorable metabolic adaptations induced by nitrate-containing
foods, dietary nitrate consumption (BR) may prove counterpro-
ductive to those with existing metabolic disease such as obesity.
Despite some similarities, Larsen et al's investigation used iso-
lated mitochondria from primary myocytes, which may account for
some of the discrepancies between the two ﬁndings. Moreover,
Larsen and colleagues used inorganic nitrate consumed orally,
likely explaining some of the other discrepancies between our
ﬁndings. Previous in vitro experiments with dietary NO precursorsdemonstrate that NO increases AMPK activation, leading to
heightened expression of PGC-1a, and potentially mitochondrial
content.14,15 On a related note, Mo et al28 previously demonstrated
that treatment of primary rat aortic smoothmuscle cells with 50mM
nitrate mediates mitochondrial biogenesis via the activation of
sirtuin 1 and PGC-1a by AMPK phosphorylation. Discrepancies
between our observations and those made by Mo and colleagues
may be a function of different experimental models or differences
in nitrate type/source. One possible explanation for this difference
may be related to nitrate bioactivation and subsequent bioavail-
ability (considered biologically inert). Given that our experimental
approach lacked commensal bacteria (microbes that express nitrate
reductases catalyzing the conversation of the nitrate anion to ni-
trite), it is possible that an alternative mechanism exists that pro-
motes nitrate-to-nitrite conversion of BR extract. Jansson et al29
reported that in vitro mammalian tissues (gastrointestinal, liver,
kidney, heart, and lung) have nitrate reductase activities, notably
higher in rodents. Using allopurinol (inhibitor of xanthine oxido-
reductase), the group further documented reduced conversation of
nitrate to nitrite, indicating a potential reduction mechanism
in vitro.29 Another limitation of our experimental approach is that
the BR used in our study was a blend of numerous other dietary
food chemicals or properties (in addition to nitrate), any of which
may have contributed to our ﬁndings. Despite this limitation, our
observations document that BR reproducibly increases mitochon-
drial content and oxygen consumption in cultured myocytes.
5. Conclusion
Nitrate-containing supplements are rapidly becoming a topic of
interest for many athletes, especially competitive endurance
R.A. Vaughan et al. / Journal of Traditional and Complementary Medicine 6 (2016) 17e2222athletes. Our data support the hypothesis that BR (containing ni-
trate) consumption may promote a favorable metabolic phenotype
in skeletal muscle cells, although the observations should be veri-
ﬁed experimentally in vivo.
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